JoyNatalieTsaiMD

Diabetes, Lipid Metabolism

Physician

Dr. Tsai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
50 Blossom St.
Thier 1051
Boston, MA 02114
Phone+1 617-726-6723

Fax+1 617-726-1703

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2007 - 2010
Northwestern University The Feinberg School of MedicineClass of 2007

PubMed

One versus 2 years of alendronate following denosumab: the CARD extension.
Joy N Tsai, Mackenzie Jordan, Hang Lee, Benjamin Z Leder
Osteoporosis International. 2024-12-01
Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis Therapies.
Margaret M Kobelski, Sabashini K Ramchand, Joy N Tsai, Benjamin Z Leder, Marie B Demay
Endocrinology. 2024-10-30
4 citations
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Sabashini K Ramchand, Joy N Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan
Osteoporosis International. 2024-02-01

Lectures

Osteoporosis and Osteoporosis Therapies
ENDO 2019 - New Orleans, LA - 3/23/2019
Fracture Risk Assessment Beyond BMD and FRAX
ENDO 2019 - New Orleans, LA - 3/23/2019